|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li Y, Arellano AR, Bare LA, Bender RA,
Strom CM and Devlin JJ: A multigene test could cost-effectively
help extend life expectancy for women at risk of hereditary breast
cancer. Value Health. 20:547–555. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ljung R, Sennerstam R, Mattsson F, Auer G
and Lagergren J: Anticoagulant medication at time of needle biopsy
for breast cancer in relation to risk of lymph node metastasis. Int
J Cancer. 135:238–241. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cho E, Kim MH, Cha SH, Cho SH, Oh SJ and
Lee JD: Breast cancer cutaneous metastasis at core needle biopsy
site. Ann Dermatol. 22:238–240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park CY, Min KN, Son JY, Park SY, Nam JS,
Kim DK and Sheen YY: An novel inhibitor of TGF-β type I receptor,
IN-1130, blocks breast cancer lung metastasis through inhibition of
epithelial-mesenchymal transition. Cancer Lett. 351:72–80. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parvani JG and Schiemann WP: Sox4, EMT
programs, and the metastatic progression of breast cancers:
Mastering the masters of EMT. Breast Cancer Res. 15:R722013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tiwari N, Tiwari VK, Waldmeier L, Balwierz
PJ, Arnold P, Pachkov M, Meyer-Schaller N, Schübeler D, van
Nimwegen E and Christofori G: Sox4 is a master regulator of
epithelial-mesenchymal transition by controlling Ezh2 expression
and epigenetic reprogramming. Cancer Cell. 23:768–783. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Borin TF, Shankar A, Angara K, Rashid MH,
Jain M, Iskander A, Ara R, Lebedyeva I, Korkaya H, Achyut BR and
Arbab AS: HET0016 decreases lung metastasis from breast cancer in
immune-competent mouse model. PLoS One. 12:e01788302017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang W, Belosay A, Yang X, Hartman JA,
Song H, Iwaniec UT, Turner RT, Churchwell MI, Doerge DR and
Helferich WG: Effects of letrozole on breast cancer
micro-metastatic tumor growth in bone and lung in mice inoculated
with murine 4T1 cells. Clin Exp Metast. 33:475–485. 2016.
View Article : Google Scholar
|
|
10
|
Ministry of Health of the PRC. GB
5749-2006 sanitary standard for drinking water. China Standard
press; Beijing: 2006, (In Chinese).
|
|
11
|
General Administration of Quality
Supervision, Inspection and Quarantine of the People's Republic of
China. GB 14924. 3-2010 Nutritional components of feeds for
experimental animals. China Quality Inspection press; Beijing:
2011, (In Chinese).
|
|
12
|
Juratli MA, Siegel ER, Nedosekin DA,
Sarimollaoglu M, Jamshidi-Parsian A, Cai C, Menyaev YA, Suen JY,
Galanzha EI and Zharov VP: In vivo long-term monitoring of
circulating tumor cells fluctuation during medical interventions.
PLoS One. 10:e01376132015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wan H, Wu X, Dong J, Yu X, Feng J, Li X
and Lu D: The action mechanism underlying the anti-tumor effects of
‘Ruaishuhou herbs’ against highly metastatic breast cancer. Tumor.
27:691–693, 709. 2007.(In Chinese).
|
|
14
|
Liebens F, Carly B, Cusumano P, Van
Beveren M, Beier B, Fastrez M and Rozenberg S: Breast cancer
seeding associated with core needle biopsies: A systematic review.
Maturitas. 62:113–123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Zhang N, Hoffman RM and Zhao M:
Surgically-induced multi-organ metastasis in an orthotopic
syngeneic imageable model of 4t1 murine breast cancer. Anticancer
Res. 35:4641–4646. 2015.PubMed/NCBI
|
|
16
|
Mathenge EG, Dean CA, Clements D,
Vaghar-Kashani A, Photopoulos S, Coyle KM, Giacomantonio M, Malueth
B, Nunokawa A, Jordan J, et al: Core needle biopsy of breast cancer
tumors increases distant metastases in a mouse model. Neoplasia.
16:950–960. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bembenek A, Li J, Loddenkemper C, Kemmner
W, Stein H, Wernecke KD and Schlag PM: Presence of mature DC-Lamp+
dendritic cells in sentinel and non-sentinel lymph nodes of breast
cancer patients. Eur J Surg Oncol. 34:514–518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang S, Zhang Y, Cong W, Liu J, Zhang Y,
Fan H, Xu Y and Lin H: Breast cancer stem-like cells can promote
metastasis by activating platelets and down-regulating antitumor
activity of natural killer cells. J Tradit Chin Med. 36:530–537.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hasegawa S, Nagano H, Konno M, Eguchi H,
Tomokuni A, Tomimaru Y, Asaoka T, Wada H, Hama N, Kawamoto K, et
al: A crucial epithelial to mesenchymal transition regulator,
Sox4/Ezh2 axis is closely related to the clinical outcome in
pancreatic cancer patients. Int J Oncol. 48:145–152. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao
X, Feng J, Zhang Y, Gao H, Liu DX, et al: SOX4 induces
epithelial-mesenchymal transition and contributes to breast cancer
progression. Cancer Res. 72:4597–4608. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen L, Xiao Z, Meng Y, Zhao Y, Han J, Su
G, Chen B and Dai J: The enhancement of cancer stem cell properties
of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and
anti-cancer drugs. Biomaterials. 33:1437–1444. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo H, Jiang Y, Ma S, Chang H, Yi C, Cao
H, Gao Y, Guo H, Hou J, Yan J, et al: EZH2 promotes invasion and
metastasis of laryngeal squamous cells carcinoma via
epithelial-mesenchymal transition through H3K27me3. Biochem Biophys
Res Commun. 479:253–259. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luan QX, Zhang BG, Li XJ and Guo MY:
miR-129-5p is downregulated in breast cancer cells partly due to
promoter H3K27m3 modification and regulates epithelial-mesenchymal
transition and multi-drug resistance. Eur Rev Med Pharmacol Sci.
20:4257–4265. 2016.PubMed/NCBI
|
|
24
|
Jang SH, Lee JE, Oh MH, Lee JH, Cho HD,
Kim KJ, Kim SY, Han SW, Kim HJ, Bae SB and Lee HJ: High EZH2
protein expression is associated with poor overall survival in
patients with luminal a breast cancer. J Breast Cancer. 19:53–60.
2016. View Article : Google Scholar : PubMed/NCBI
|
